Bayer Partners with VeChain for traceability program

May 28, 2020 — Kolin Lukas

One of the leading companies in the global pharmaceutical industry, Bayer China, has revealed it is working with VeChain, a pioneering public blockchain startup, to co-develop CSecure, a blockchain powered Clinical Trial Traceability Platform for drugs.

The partnership was disclosed to the public by Bayer China, following a public interview given to VCBeat, a Chinese healthcare-focused media company and website. The public interview has put VeChain to the forefront as a technical infrastructure leader in the increasingly digitized medical healthcare sector.

The interview also dives deep on how this partnership came about. In particular, it explained why Bayer China, a pharmaceutical giant with history in the Greater China region as early as the year 1882, chose to trust and partner with VeChain, a fledgling blockchain technology start-up that was only established less than 5 years ago. VeChain was specifically selected as the only company capable of helping Bayer to achieve its internal requirements for digitizing their core services and solving long-standing problems that exist in the healthcare and medical industry.

VeChain Becomes “Partner-for-Life” through Bayer’s G4A Program